Literature DB >> 24128389

Influence of renal function on long-term graft survival and patient survival in renal transplant recipients.

J Smith-Palmer1, A Kalsekar, W Valentine.   

Abstract

OBJECTIVES: Renal function post kidney transplantation is an outcome of interest for both clinicians and regulators evaluating immunosuppressive treatments post-transplantation. The current review sought to provide a synopsis of currently available literature examining the relationship between post-transplantation renal function and long-term graft survival and patient survival.
METHODS: A systematic literature review was performed using the PubMed, EMBASE and Cochrane Library databases. The search strategy was designed based on high level Medical Subject Heading (MeSH) terms and designed to capture studies published in English to 2012 and identified a total of 2683 unique hits; for inclusion studies were required to have >100 patients. Following two rounds of screening, a total of 27 studies were included in the final review (26 of which were identified via the literature review and one study was identified via searches of the reference sections of included studies).
RESULTS: The consensus among studies was that lower post-transplantation GFR, in particular 12 month GFR, was consistently and significantly associated with an increased risk for overall graft loss, death-censored graft loss and all-cause mortality in both univariate and multivariate analyses. The magnitude of the association between reduced GFR and outcomes was greater for death-censored graft loss versus overall graft loss and for graft loss in comparison with overall patient mortality. The predictive utility of GFR alone in predicting long-term outcomes was reported to be limited.
CONCLUSIONS: Lower GFR and greater rates of decline in GFR post-transplantation are associated with an increased risk for graft loss (overall and death-censored) and all-cause mortality; however, the predictive utility of GFR alone in predicting long-term outcomes is limited.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24128389     DOI: 10.1185/03007995.2013.855189

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  7 in total

1.  Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy.

Authors:  E Abdel-Hady Algharably; J Beige; R Kreutz; J Bolbrinker
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

2.  Prognostic value for long-term graft survival of estimated glomerular filtration rate and proteinuria quantified at 3 months after kidney transplantation.

Authors:  Clément Mottola; Nicolas Girerd; Kevin Duarte; Alice Aarnink; Magali Giral; Jacques Dantal; Valérie Garrigue; Georges Mourad; Fanny Buron; Emmanuel Morelon; Marc Ladrière; Michèle Kessler; Luc Frimat; Sophie Girerd
Journal:  Clin Kidney J       Date:  2020-04-26

3.  Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation.

Authors:  Luuk Hilbrands; Klemens Budde; Maria Irene Bellini; Fritz Diekmann; Lucrezia Furian; Josep Grinyó; Uwe Heemann; Dennis A Hesselink; Alexandre Loupy; Rainer Oberbauer; Liset Pengel; Marlies Reinders; Stefan Schneeberger; Maarten Naesens
Journal:  Transpl Int       Date:  2022-05-20       Impact factor: 3.842

4.  Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome.

Authors:  Daan Kremer; Adrian Post; António W Gomes-Neto; Dion Groothof; Setor K Kunutsor; Tom Nilsen; Clara Hidden; Erling Sundrehagen; Michele F Eisenga; Gerjan Navis; Stephan J L Bakker
Journal:  Clin Kidney J       Date:  2021-11-08

5.  The Korean Organ Transplantation Registry (KOTRY): an overview and summary of the kidney-transplant cohort.

Authors:  Hee Jung Jeon; Tai Yeon Koo; Man Ki Ju; Dong-Wan Chae; Soo Jin Na Choi; Myoung Soo Kim; Jung-Hwa Ryu; Jong Cheol Jeon; Curie Ahn; Jaeseok Yang
Journal:  Kidney Res Clin Pract       Date:  2022-07-28

6.  Everolimus-facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2-year results from the subgroup analysis of the TRANSFORM study.

Authors:  Yoshihiko Watarai; Romina Danguilan; Concesa Casasola; Shen-Shin Chang; Prajej Ruangkanchanasetr; Terence Kee; Hin Seng Wong; Takashi Kenmochi; Angel Joaquin Amante; Kuo-Hsiung Shu; Atiporn Ingsathit; Peter Bernhardt; Maria Pilar Hernandez-Gutierrez; Duck Jong Han; Myoung Soo Kim
Journal:  Clin Transplant       Date:  2021-09-23       Impact factor: 3.456

7.  EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial.

Authors:  Sophie Girerd; Luc Frimat; Didier Ducloux; Yannick Le Meur; Christophe Mariat; Bruno Moulin; Christiane Mousson; Philippe Rieu; Nassim Dali-Youcef; Ludovic Merckle; Xavier Lepage; Patrick Rossignol; Nicolas Girerd; Frédéric Jaisser
Journal:  Trials       Date:  2018-10-30       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.